Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere)
Simpson, Eric L, Gooderham, Melinda, Wollenberg, Andreas, Weidinger, Stephan, Armstrong, April, Soung, Jennifer, Ferrucci, Silvia, Lima, Renata Gontijo, Witte, Michael M, Xu, Wen, ElMaraghy, Hany, Natalie, Chitra R, Pierce, Evangeline, Blauvelt, Andrew
Published in JAMA dermatology (Chicago, Ill.) (01.02.2023)
Published in JAMA dermatology (Chicago, Ill.) (01.02.2023)
Get more information
Journal Article
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
Blauvelt, Andrew, Thyssen, Jacob P, Guttman-Yassky, Emma, Bieber, Thomas, Serra-Baldrich, Esther, Simpson, Eric, Rosmarin, David, Elmaraghy, Hany, Meskimen, Eric, Natalie, Chitra R, Liu, Zhuqing, Xu, Chenjia, Pierce, Evangeline, Morgan-Cox, MaryAnn, Garcia Gil, Esther, Silverberg, Jonathan I
Published in British journal of dermatology (1951) (24.05.2023)
Published in British journal of dermatology (1951) (24.05.2023)
Get full text
Journal Article
Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study
Paller, Amy S., Flohr, Carsten, Eichenfield, Lawrence F., Irvine, Alan D., Weisman, Jamie, Soung, Jennifer, Pinto Correia, Ana, Natalie, Chitra R., Rodriguez Capriles, Claudia, Pierce, Evangeline, Reifeis, Sarah, Gontijo Lima, Renata, Armengol Tubau, Clara, Laquer, Vivian, Weidinger, Stephan
Published in Dermatology and therapy (01.07.2023)
Published in Dermatology and therapy (01.07.2023)
Get full text
Journal Article
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
Stein Gold, Linda, Thaçi, Diamant, Thyssen, Jacob P., Gooderham, Melinda, Laquer, Vivian, Moore, Angela, Natalie, Chitra R., Zhao, Fangyi, Meskimen, Eric, Elmaraghy, Hany, Montmayeur, Sonia, Gallo, Gaia, Jimenez, Gemma, de Bruin-Weller, Marjolein
Published in American journal of clinical dermatology (01.07.2023)
Published in American journal of clinical dermatology (01.07.2023)
Get full text
Journal Article
Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population
Corren, Jonathan, Szefler, Stanley J, Sher, Ellen, Korenblat, Phillip, Soong, Weily, Hanania, Nicola A, Berman, Gary, Brusselle, Guy, Zitnik, Ralph, Natalie, Chitra R, Sun, Luna, Siu, Kimberly, Wu, Wen-Shuo, Lio, Peter, Armstrong, April W
Published in The journal of allergy and clinical immunology in practice (Cambridge, MA) (01.05.2024)
Published in The journal of allergy and clinical immunology in practice (Cambridge, MA) (01.05.2024)
Get more information
Journal Article
Lebrikizumab Decreases Inflammatory Biomarkers in Patients with Asthma: Data from Randomized Phase 3 Trials (LAVOLTA I and II)
Szefler, Stanley, Corren, Jonathan, Silverberg, Jonathan, Okragly, Angela, Sun, Zhe, Natalie, Chitra, Zitnik, Ralph, Siu, Kimberly, Blauvelt, Andrew
Published in Journal of allergy and clinical immunology (01.02.2023)
Published in Journal of allergy and clinical immunology (01.02.2023)
Get full text
Journal Article
53143 Clinical measures of improvement in atopic dermatitis are correlated with reductions in relevant biomarkers in patients treated with lebrikizumab
Guttman-Yassky, Emma, Sun, Zhe, Nickoloff, Brian J., Natalie, Chitra R., Gallo, Gaia, Wolf, Eric, Eyerich, Kilian, Aparici, Monica, Benschop, Robert J.
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
628 - Clinical measures of improvement in atopic dermatitis are correlated with reductions in relevant biomarkers in patients treated with lebrikizumab
Guttman-Yassky, Emma, Okragly, Angela, Sun, Zhe, Nickoloff, Brian J, Natalie, Chitra R, Gallo, Gaia, Wolf, Eric, Eyerich, Kilian, Aparici, Monica, Benschop, Robert J
Published in British journal of dermatology (1951) (08.08.2024)
Published in British journal of dermatology (1951) (08.08.2024)
Get full text
Journal Article
496 - Conjunctivitis does not increase with longer duration of lebrikizumab exposure in patients with moderate-to-severe atopic dermatitis
Armstrong, April, Wollenberg, Andreas, de Bruin-Weller, Marjolein, Lio, Peter, Natalie, Chitra R, Zhao, Fangyi, Atwater, Amber Reck, Jimenez, Gemma, Chu, Chia-Yu, Vestergaard, Christian
Published in British journal of dermatology (1951) (07.02.2024)
Published in British journal of dermatology (1951) (07.02.2024)
Get full text
Journal Article
42917 Safety and efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: an open-label study
Paller, Amy, Flohr, Carsten, Eichenfield, Lawrence F., Irvine, Alan, Correia, Ana Pinto, Natalie, Chitra R., Pierce, Evangeline, Reifeis, Sarah, Lima, Renata Gontijo, Laquer, Vivian, Weidinger, Stephan
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
399 Pooled safety analysis of lebrikizumab in patients with uncontrolled asthma from three randomized clinical trials
Corren, Jonathan, Szefler, Stanley J, Armstrong, April W , Natalie, Chitra R, Zitnik, Ralph , Zhao, Fangyi, Siu, Kimberly, Lio, Peter A , Mourey, Robert J
Published in British journal of dermatology (1951) (20.06.2023)
Published in British journal of dermatology (1951) (20.06.2023)
Get full text
Journal Article
401 Safety and efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: an open-label study
Paller, Amy, Flohr, Carsten, Eichenfield, Lawrence F, Irvine, Alan, Pinto-Correia, Ana , Natalie, Chitra R, Pierce, Evangeline , Reifeis, Sarah, Lima, Renata Gontijo, Laquer, Vivian, Weidinger, Stephan , Isho, Nadine
Published in British journal of dermatology (1951) (20.06.2023)
Published in British journal of dermatology (1951) (20.06.2023)
Get full text
Journal Article
314 Injection site reactions from an integrated analysis of phase 2 and phase 3 clinical trials of lebrikizumab treatment in moderate-to-severe atopic dermatitis
Gooderham, Melinda, Shi, Vivian Y, Wollenberg, Andreas, Thyssen, Jacob P, Torres, Tiago, Gil, Esther Garcia, Bardolet, Laia, Natalie, Chitra R, Atwater, Amber R, Zhao, Fangyi, Blauvelt, Andrew
Published in British journal of dermatology (1951) (25.01.2023)
Published in British journal of dermatology (1951) (25.01.2023)
Get full text
Journal Article
732 - EASI 90 response sustained up to 38 weeks after lebrikizumab withdrawal despite negligible serum concentrations
Silverberg, Jonathan I, Bieber, Thomas, Eyerich, Kilian, Armstrong, April W, Nickoloff, Brian J, Natalie, Chitra R, Gallo, Gaia, Okragly, Angela, Xu, Chenjia, Moser, Brian, Rueda, Maria Jose, Elmaraghy, Hany, Uluckan, Ozge, Gudjonsson, Johann E
Published in British journal of dermatology (1951) (08.08.2024)
Published in British journal of dermatology (1951) (08.08.2024)
Get full text
Journal Article
493 - Lebrikizumab does not impact vaccine-induced immune responses: results from a phase 3 study in adult patients with moderate-to-severe atopic dermatitis
Soung, Jennifer, Laquer, Vivian, Merola, Joseph F, Forman, Seth, Elmaraghy, Hany, Meskimen, Eric, Hu, Chaoran, Natalie, Chitra R, Pierce, Evangeline, Torisu-Itakura, Hitoe, Gil, Esther Garcia, Jarell, Abel D
Published in British journal of dermatology (1951) (07.02.2024)
Published in British journal of dermatology (1951) (07.02.2024)
Get full text
Journal Article
373 Safety of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis: data from eight trials
Gold, Linda Stein, Thaçi, Diamant, Thyssen, Jacob P , Gooderham, Melinda, Laquer, Vivian , Natalie, Chitra R, Zhao, Fangyi , Meskimen, Eric, ElMaraghy, Hany, Montmayeur, Sonia , Jimenez, Gemma, de Bruin-Weller, Marjolein
Published in British journal of dermatology (1951) (20.06.2023)
Published in British journal of dermatology (1951) (20.06.2023)
Get full text
Journal Article
322 Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized, double-blinded, placebo-controlled phase 3 trials (ADvocate1 and ADvocate2)
Blauvelt, Andrew, Thyssen, Jacob P, Guttman-Yassky, Emma , Bieber, Thomas, Carrascosa, Jose Manuel, Simpson, Eric, Rosmarin, David , Elmaraghy, Hany, Meskimen, Eric, Natalie, Chitra R, Liu, Zhuqing, Xu, Chenjia, Pierce, Evangeline, Morgan-Cox, MaryAnn, Silverberg, Jonathan I
Published in British journal of dermatology (1951) (25.01.2023)
Published in British journal of dermatology (1951) (25.01.2023)
Get full text
Journal Article
Lebrikizumab Monotherapy Reduces Flares in Patients with Moderate-to-Severe Atopic Dermatitis
Del Rosso, James, Kwong, Pearl, Hussain, Iftikhar, Barbarot, Sebastien, Carrascosa, Jose, Rueda, Maria, Atwater, Amber, Elmaraghy, Hany, Sun, Luna, Chen, Sherry, Natalie, Chitra, Weidinger, Stephan
Published in Skin (Milwood, N.Y.) (13.03.2023)
Published in Skin (Milwood, N.Y.) (13.03.2023)
Get full text
Journal Article
Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis
Armstrong, April, Wollenberg, Andreas, De Bruin-Weller, Marjolein, Lio, Peter A., Natalie, Chitra R., Zhao, Fangyi, Reck Atwater, Amber, Jimenez, Gemma, Chu, Chia-Yu, Vestergaard, Christian
Published in Skin (Milwood, N.Y.) (13.11.2023)
Published in Skin (Milwood, N.Y.) (13.11.2023)
Get full text
Journal Article